These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 20932009

  • 1. 5-Piperazinyl-3-sulfonylindazoles as potent and selective 5-hydroxytryptamine-6 antagonists.
    Liu KG, Robichaud AJ, Bernotas RC, Yan Y, Lo JR, Zhang MY, Hughes ZA, Huselton C, Zhang GM, Zhang JY, Kowal DM, Smith DL, Schechter LE, Comery TA.
    J Med Chem; 2010 Nov 11; 53(21):7639-46. PubMed ID: 20932009
    [Abstract] [Full Text] [Related]

  • 2. Identification of 3-sulfonylindazole derivatives as potent and selective 5-HT(6) antagonists.
    Liu KG, Robichaud AJ, Greenfield AA, Lo JR, Grosanu C, Mattes JF, Cai Y, Zhang GM, Zhang JY, Kowal DM, Smith DL, Di L, Kerns EH, Schechter LE, Comery TA.
    Bioorg Med Chem; 2011 Jan 01; 19(1):650-62. PubMed ID: 21093272
    [Abstract] [Full Text] [Related]

  • 3. Identification of a novel series of 3-piperidinyl-5-sulfonylindazoles as potent 5-HT6 ligands.
    Liu KG, Lo JR, Comery TA, Zhang GM, Zhang JY, Kowal DM, Smith DL, Di L, Kerns EH, Schechter LE, Robichaud AJ.
    Bioorg Med Chem Lett; 2009 Jun 15; 19(12):3214-6. PubMed ID: 19433358
    [Abstract] [Full Text] [Related]

  • 4. 1-Sulfonylindazoles as potent and selective 5-HT6 ligands.
    Liu KG, Lo JR, Comery TA, Zhang GM, Zhang JY, Kowal DM, Smith DL, Di L, Kerns EH, Schechter LE, Robichaud AJ.
    Bioorg Med Chem Lett; 2009 May 01; 19(9):2413-5. PubMed ID: 19345582
    [Abstract] [Full Text] [Related]

  • 5. Effect of several 5-hydroxytryptamine(1A) receptor ligands on the micturition reflex in rats: comparison with WAY 100635.
    Testa R, Guarneri L, Poggesi E, Angelico P, Velasco C, Ibba M, Cilia A, Motta G, Riva C, Leonardi A.
    J Pharmacol Exp Ther; 1999 Sep 01; 290(3):1258-69. PubMed ID: 10454502
    [Abstract] [Full Text] [Related]

  • 6. Bicyclic heteroarylpiperazines as selective brain penetrant 5-HT6 receptor antagonists.
    Ahmed M, Briggs MA, Bromidge SM, Buck T, Campbell L, Deeks NJ, Garner A, Gordon L, Hamprecht DW, Holland V, Johnson CN, Medhurst AD, Mitchell DJ, Moss SF, Powles J, Seal JT, Stean TO, Stemp G, Thompson M, Trail B, Upton N, Winborn K, Witty DR.
    Bioorg Med Chem Lett; 2005 Nov 01; 15(21):4867-71. PubMed ID: 16143522
    [Abstract] [Full Text] [Related]

  • 7. Modification of the structure of 4, 6-disubstituted 2-(4-alkyl-1-piperazinyl)pyridines: synthesis and their 5-HT2A receptor activity.
    Paluchowska MH, Bojarski AJ, Bugno R, Charakchieva-Minol S, Wesołowska A.
    Arch Pharm (Weinheim); 2003 Apr 01; 336(2):104-10. PubMed ID: 12761763
    [Abstract] [Full Text] [Related]

  • 8. 5-Cyclic amine-3-arylsulfonylindazoles as novel 5-HT6 receptor antagonists.
    Haydar SN, Yun H, Andrae PM, Mattes J, Zhang J, Kramer A, Smith DL, Huselton C, Graf R, Aschmies S, Schechter LE, Comery TA, Robichaud AJ.
    J Med Chem; 2010 Mar 25; 53(6):2521-7. PubMed ID: 20170099
    [Abstract] [Full Text] [Related]

  • 9. Indole-3-piperazinyl derivatives: novel chemical class of 5-HT(6) receptor antagonists.
    Nirogi RV, Deshpande AD, Kambhampati R, Badange RK, Kota L, Daulatabad AV, Shinde AK, Ahmad I, Kandikere V, Jayarajan P, Dubey PK.
    Bioorg Med Chem Lett; 2011 Jan 01; 21(1):346-9. PubMed ID: 21134749
    [Abstract] [Full Text] [Related]

  • 10. The synthesis and biological evaluation of quinolyl-piperazinyl piperidines as potent serotonin 5-HT1A antagonists.
    Childers WE, Havran LM, Asselin M, Bicksler JJ, Chong DC, Grosu GT, Shen Z, Abou-Gharbia MA, Bach AC, Harrison BL, Kagan N, Kleintop T, Magolda R, Marathias V, Robichaud AJ, Sabb AL, Zhang MY, Andree TH, Aschmies SH, Beyer C, Comery TA, Day M, Grauer SM, Hughes ZA, Rosenzweig-Lipson S, Platt B, Pulicicchio C, Smith DE, Sukoff-Rizzo SJ, Sullivan KM, Adedoyin A, Huselton C, Hirst WD.
    J Med Chem; 2010 May 27; 53(10):4066-84. PubMed ID: 20443629
    [Abstract] [Full Text] [Related]

  • 11. Synthesis by microwave irradiation and binding properties of novel 5-HT(1A) receptor ligands.
    Caliendo G, Fiorino F, Perissutti E, Severino B, Gessi S, Cattabriga E, Borea PA, Santagada V.
    Eur J Med Chem; 2001 May 27; 36(11-12):873-86. PubMed ID: 11755230
    [Abstract] [Full Text] [Related]

  • 12. Structure-activity relationship studies of CNS agents. Part 24: New analogs of N-tert.-butyl-3-[4-(2-methoxyphenyl)-1-piperazinyl]-2-phenylpropanamide (WAY-100135).
    Boksa J, Klodzińska A, Charakchieva-Minol S, Chojnacka-Wójcik E, Mokrosz JL.
    Pharmazie; 1996 Feb 27; 51(2):72-6. PubMed ID: 8720802
    [Abstract] [Full Text] [Related]

  • 13. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
    Leopoldo M, Berardi F, Colabufo NA, Contino M, Lacivita E, Niso M, Perrone R, Tortorella V.
    J Med Chem; 2004 Dec 16; 47(26):6616-24. PubMed ID: 15588097
    [Abstract] [Full Text] [Related]

  • 14. Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist.
    Riemer C, Borroni E, Levet-Trafit B, Martin JR, Poli S, Porter RH, Bös M.
    J Med Chem; 2003 Mar 27; 46(7):1273-6. PubMed ID: 12646038
    [Abstract] [Full Text] [Related]

  • 15. 8-Piperazinyl-2,3-dihydropyrrolo[3,2-g]isoquinolines: potent, selective, orally bioavailable 5-HT1 receptor ligands.
    Heightman TD, Gaster LM, Pardoe SL, Pilleux JP, Hadley MS, Middlemiss DN, Price GW, Roberts C, Scott CM, Watson JM, Gordon LJ, Holland VA, Powles J, Riley GJ, Stean TO, Trail BK, Upton N, Austin NE, Ayrton AD, Coleman T, Cutler L.
    Bioorg Med Chem Lett; 2005 Oct 01; 15(19):4370-4. PubMed ID: 16039851
    [Abstract] [Full Text] [Related]

  • 16. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.
    Lacivita E, Patarnello D, Stroth N, Caroli A, Niso M, Contino M, De Giorgio P, Di Pilato P, Colabufo NA, Berardi F, Perrone R, Svenningsson P, Hedlund PB, Leopoldo M.
    J Med Chem; 2012 Jul 26; 55(14):6375-80. PubMed ID: 22738316
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and structure-activity relationship (SAR) of (5,7-disubstituted 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidin-2-yl)-methylamines as potent serotonin 5-HT(6) receptor (5-HT(6)R) antagonists.
    Ivachtchenko AV, Golovina ES, Kadieva MG, Kysil VM, Mitkin OD, Tkachenko SE, Okun IM.
    J Med Chem; 2011 Dec 08; 54(23):8161-73. PubMed ID: 22029285
    [Abstract] [Full Text] [Related]

  • 18. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors.
    Cappelli A, Anzini M, Vomero S, Canullo L, Mennuni L, Makovec F, Doucet E, Hamon M, Menziani MC, De Benedetti PG, Bruni G, Romeo MR, Giorgi G, Donati A.
    J Med Chem; 1999 May 06; 42(9):1556-75. PubMed ID: 10229626
    [Abstract] [Full Text] [Related]

  • 19. 3-(Arylsulfonyl)-1-(azacyclyl)-1H-indoles are 5-HT(6) receptor modulators.
    Bernotas RC, Antane S, Shenoy R, Le VD, Chen P, Harrison BL, Robichaud AJ, Zhang GM, Smith D, Schechter LE.
    Bioorg Med Chem Lett; 2010 Mar 01; 20(5):1657-60. PubMed ID: 20138763
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.
    Schaus JM, Thompson DC, Bloomquist WE, Susemichel AD, Calligaro DO, Cohen ML.
    J Med Chem; 1998 May 21; 41(11):1943-55. PubMed ID: 9599243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.